The Ministry of Public Health reiterates that the COVID-19 vaccine booster is still important in at-risk groups, especially the elderly with comorbidities.
Mr. Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health Referring to the case of the consideration of the loan expenditure screening committee (COD) to approve the Department of Disease Control to extend the deadline for the COVID-19 vaccine procurement program, that the Cabinet has acknowledged such results, the Department of Disease Control and the Ministry public health It has previously undertaken a parallel on the subject of negotiations with the manufacturer of the COVID vaccine. because now the situation with COVID is not the same as before People eased their concerns. Rarely come for booster vaccination as they should. Therefore, there is a negotiation to reduce the booster needle. Let’s change to ready-made antibodies (LAAB) instead because LAAB is not just immunization. But for people who are not vaccinated and infected, LAAB can still be used to treat it, which is called both a vaccine and a cure. But with a higher price than vaccines Therefore, I would like to leave that the vaccine is still necessary, especially at risk groups should receive a booster needle and be injected together with the influenza vaccine. As for the progress of the self-produced COVID vaccine in Thailand Progress has been made and progress will be announced later this month.
On the side of Dr. Nakorn Premsri, director of the National Vaccine Institute, said that the COVID vaccine in Thailand will be used as a booster vaccine. because although developed from the original species but also effective in preventing violence especially risk groups Elderly people with comorbidities when given a booster vaccine can reduce their severity. which today in Thailand there are still infected people who are still intubated especially the elderly with comorbidities vaccination in this group Immunity will occur less than the average person or the landscape will fall faster, so the vaccine that Thailand can develop will come to use at this point. Along with the Thai registered vaccines, it can also be developed to support new strains. because the future does not know how to change Now the Omicron species, the next 6 months may change. The first registration will be the basis for accommodating new species.
news information and sources
Correspondent: Naruemon Udomporn / IPST.
Arranged by: Sawita Thanawat
Source: Radio-Radio Station of Thailand
2023-09-01 17:10:53
#Ministry #Public #Health #emphasizes #COVID19 #vaccine
